They offer plenty of upside and solid dividend growth. It's easy to find stocks that are lagging broader equities, even in a bull market like the one we're currently in. It's harder to find beaten-down stocks that still look worth buying and holding onto for a while. Some corporations are condemned to deliver subpar financial results and stock market performances practically in perpetuity. Thankfully, Bristol Myers Squibb (BMY 2.45%) and Pfizer (PFE 1.19%), two drugmakers that are failing to keep pace with ...